MRI Quantitative T2* Mapping to Predict Dominant Composition of In Vitro Thrombus

References

1. 1.↵
   2. Goyal M,
   3. Menon BK,
   4. van Zwam WH, et al

   ; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31 doi:10.1016/S0140-6736(16)00163-X pmid:26898852

   CrossRefPubMed
2. 2.↵
   2. Hashimoto T,
   3. Hayakawa M,
   4. Funatsu N, et al

   . Histopathologic analysis of retrieved thrombi associated with successful reperfusion after acute stroke thrombectomy. Stroke 2016;47:3035–37 doi:10.1161/STROKEAHA.116.015228 pmid:27780903

   Abstract/FREE Full Text
3. 3.↵
   2. Brinjikji W,
   3. Duffy S,
   4. Burrows A, et al

   . Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review. J Neurointerv Surg 2017;9:529–34 doi:10.1136/neurintsurg-2016-012391 pmid:27166383

   Abstract/FREE Full Text
4. 4.↵
   2. Rovira A,
   3. Orellana P,
   4. Alvarez-Sabín J, et al

   . Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology 2004;232:466–73 doi:10.1148/radiol.2322030273 pmid:15215546

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Liebeskind DS,
   3. Sanossian N,
   4. Yong WH, et al

   . CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke 2011; 42:1237–43 doi:10.1161/STROKEAHA.110.605576 pmid:21393591

   Abstract/FREE Full Text
6. 6.↵
   2. Marder VJ,
   3. Chute DJ,
   4. Starkman S, et al

   . Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006;37:2086–93 doi:10.1161/01.STR.0000230307.03438.94 pmid:16794209

   Abstract/FREE Full Text
7. 7.↵
   2. Boeckh-Behrens T,
   3. Schubert M,
   4. Förschler A, et al

   . The impact of histological clot composition in embolic stroke. Clin Neuroradiol 2016;26:189–97 doi:10.1007/s00062-014-0347-x pmid:25261075

   CrossRefPubMed
8. 8.↵
   2. Bourcier R,
   3. Détraz L,
   4. Serfaty JM, et al

   . MRI interscanner agreement of the association between the susceptibility vessel sign and histologic composition of thrombi. J Neuroimaging 2017;27:577–82 doi:10.1111/jon.12464 pmid:28771893

   CrossRefPubMed
9. 9.↵
   2. Hanneman K,
   3. Nguyen ET,
   4. Thavendiranathan P, et al

   . Quantification of myocardial extracellular volume fraction with cardiac MR imaging in thalassemia major. Radiology 2016;279:720–30 doi:10.1148/radiol.2015150341 pmid:26653680

   CrossRefPubMed
10. 10.↵
    2. Gandon Y,
    3. Olivié D,
    4. Guyader D, et al

    . Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357–62 doi:10.1016/S0140-6736(04)15436-6 pmid:15070565

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Bourcier R,
    3. Brecheteau N,
    4. Costalat V, et al

    . MRI quantitative T2* mapping on thrombus to predict recanalization after endovascular treatment for acute anterior ischemic stroke. J Neuroradiol 2017;44:241–46 doi:10.1016/j.neurad.2017.03.006 pmid:28478114

    CrossRefPubMed
12. 12.↵
    2. Duffy S,
    3. Farrell M,
    4. McArdle K, et al

    . Novel methodology to replicate clot analogs with diverse composition in acute ischemic stroke. J Neurointerv Surg 2017;9:486–91 doi:10.1136/neurintsurg-2016-012308 pmid:27127231

    Abstract/FREE Full Text
13. 13.↵
    2. Koo TK,
    3. Li MY

    . A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15:155–63 doi:10.1016/j.jcm.2016.02.012 pmid:27330520

    CrossRefPubMed
14. 14.↵
    2. Goyal M,
    3. Demchuk AM,
    4. Menon BK, et al

    ; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30 doi:10.1056/NEJMoa1414905 pmid:25671798

    CrossRefPubMed
15. 15.↵
    2. Campbell BC,
    3. Mitchell PJ,
    4. Kleinig TJ, et al

    ; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372:1009–18 doi:10.1056/NEJMoa1414792 pmid:25671797

    CrossRefPubMed
16. 16.↵
    2. Berkhemer OA,
    3. Fransen PS,
    4. Beumer D, et al

    . A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20 doi:10.1056/NEJMoa1411587 pmid:25517348

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Jovin TG,
    3. Chamorro A,
    4. Cobo E, et al

    ; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372:2296–306 doi:10.1056/NEJMoa1503780 pmid:25882510

    CrossRefPubMed
18. 18.↵
    2. Saver JL,
    3. Goyal M,
    4. Bonafe A, et al

    ; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372:2285–95 doi:10.1056/NEJMoa1415061 pmid:25882376

    CrossRefPubMed
19. 19.↵
    2. Boeckh-Behrens T,
    3. Kleine JF,
    4. Zimmer C, et al

    . Thrombus histology suggests cardioembolic cause in cryptogenic stroke. Stroke 2016;47:1864–71 doi:10.1161/STROKEAHA.116.013105 pmid:27197854

    Abstract/FREE Full Text
20. 20.↵
    2. Fennell VS,
    3. Setlur Nagesh SV,
    4. Meess KM, et al

    . What to do about fibrin rich “tough clots”? Comparing the Solitaire stent retriever with a novel geometric clot extractor in an in vitro stroke model. J Neurointerv Surg 2018;10:907–10 doi:10.1136/neurintsurg-2017-013507 pmid:29352061

    Abstract/FREE Full Text
21. 21.↵
    2. Machi P,
    3. Jourdan F,
    4. Ambard D, et al

    . Experimental evaluation of stent retrievers' mechanical properties and effectiveness. J Neurointerv Surg 2017;9:257–63 doi:10.1136/neurintsurg-2015-012213 pmid:27016318

    Abstract/FREE Full Text
22. 22.↵
    2. Soize S,
    3. Batista AL,
    4. Rodriguez Regent C, et al

    . Susceptibility vessel sign on T2* magnetic resonance imaging and recanalization results of mechanical thrombectomy with stent retrievers: a multicentre cohort study. Eur J Neurol 2015;22:967–72 doi:10.1111/ene.12693 pmid:25786977

    CrossRefPubMed
23. 23.↵
    2. Naggara O,
    3. Raymond J,
    4. Domingo Ayllon M, et al

    . T2* “susceptibility vessel sign” demonstrates clot location and length in acute ischemic stroke. PLoS One 2013;8:e76727 doi:10.1371/journal.pone.0076727 pmid:24146915

    CrossRefPubMed
24. 24.↵
    2. Kimura K,
    3. Sakamoto Y,
    4. Iguchi Y, et al

    . Clinical and MRI scale to predict very poor outcome in tissue plasminogen activator patients. Eur Neurol 2011;65:291–95 doi:10.1159/000327690 pmid:21508643

    CrossRefPubMed
25. 25.↵
    2. Aoki J,
    3. Kimura K,
    4. Shibazaki K, et al

    . Location of the susceptibility vessel sign on T2*-weighted MRI and early recanalization within 1 hour after tissue plasminogen activator administration. Cerebrovasc Dis Extra 2013;3:111–20 doi:10.1159/000354848 pmid:24163686

    CrossRefPubMed
26. 26.↵
    2. Hodel J,
    3. Rodallec M,
    4. Gerber S, et al

    . Susceptibility weighted magnetic resonance sequences “SWAN, SWI and VenoBOLD”: technical aspects and clinical applications [in French]. J Neuroradiol 2012;39:71–86 doi:10.1016/j.neurad.2011.11.006 pmid:22342939

    CrossRefPubMed
27. 27.↵
    2. Kato A,
    3. Shinohara Y,
    4. Yamashita E, et al

    . Usefulness of R2* maps generated by iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantitation sequence for cerebral artery dissection. Neuroradiology 2015;57:909–15 doi:10.1007/s00234-015-1549-x pmid:26070299

    CrossRefPubMed
28. 28.↵
    2. Shinohara Y,
    3. Kato A,
    4. Yamashita E, et al

    . R2* map by IDEAL IQ for acute cerebral infarction: compared with susceptibility vessel sign on T2*-weighted imaging. Yonago Acta Med 2016;59:204–09 pmid:27708535

    PubMed
29. 29.↵
    2. Santos EM,
    3. Marquering HA,
    4. den Blanken MD, et al

    ; MR CLEAN Investigators. Thrombus permeability is associated with improved functional outcome and recanalization in patients with ischemic stroke. Stroke 2016;47:732–41 doi:10.1161/STROKEAHA.115.011187 pmid:26846859

    Abstract/FREE Full Text